Autopsy report · NCT02523092
Use of CXCL9 as a Biomarker of Acthar Efficacy
Cause of deathOther
“sponsor closed study down”
Life of this trial
- Registered 7 years 3 months before it started.
- Ran for about 2 years 3 months before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- University of California, San Francisco
- Sponsor type
- University, hospital or other
- Conditions
- Sarcoidosis
- Interventions
- Acthar gel
- Participants
- 2
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.